2 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
Follow Urogenital Abnormalities: new trials by email Literature Review of Urogenital Abnormalities trials Research Report on Urogenital Abnormalities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Liposomal Bupivacaine vs Standard Penile Block for Hypospadias Repair Liposomal bupivacaine, Bupivacaine - Hypospadias | Phase 1 | Withdrawn | University of Texas Southwestern Medical Center | 2021-07-01 | 2021-08-16 | |
| Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia NBI-77860 - Congenital Adrenal Hyperplasia | Phase 1 | Withdrawn | Neurocrine Biosciences | 2015-02-01 | 2015-06-11 |
Adrenal Gland Diseases (1) · Adrenal Hyperplasia, Congenital (1) · Adrenocortical Hyperfunction (1) · Adrenogenital Syndrome (1) · Congenital Abnormalities (1) · Congenital adrenal hyperplasia due to 21 hydroxylase deficiency (1) · Disorders of Sex Development (1) · Endocrine System Diseases (1) · Genetic Diseases, Inborn (1) · Gonadal Disorders (1) · Hyperplasia (1) · Hypospadias (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1) · Pathologic Processes (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Congenital Abnormalities (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Nutritional and Metabolic Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Penile Diseases (1)
Bupivacaine (1) · NBI 77860 (1)
Neurocrine Biosciences (1) · University of Texas Southwestern Medical Center (1)
United States (1)
Craig Peters, MD (1)